(Q50896070)
Statements
Relative bioavailability of ondansetron 8-mg oral tablets versus two extemporaneous 16-mg suppositories: formulation and gender differences (English)
1 reference
Jann MW
1 reference
ZumBrunnen TL
1 reference
Tenjarla SN
1 reference
Ward ES Jr
1 reference
Weidler DJ
1 reference
1 March 1998
1 reference
18
1 reference
2
1 reference
288-294
1 reference